Hoover R David's Form 4 filing
Elanco Animal Health Inc (ELAN) · filed Aug 17, 2021
- Accession no.
- 0000950138-21-000416
- Filed
- Aug 17, 2021
- Trade date
- Aug 13-16, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $313.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoover R DavidCIK 0001186033 | Director, See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock | PPurchaseAcquired | +2,000 | $30.75 | +$61,500 | 82,000 | Indirect | |
| Aug 16, 2021 | Common Stock | PPurchaseAcquired | +8,000 | $31.45F1 | +$251,600 | 90,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.2983 to $31.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Chairman of the Elanco Board of Directors